Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study.
Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Efken P, Mohl W, Hoffstadt M, Krause T, Schweitzer A, Schnoy E, Atreya R, Teich N, Trentmann L, Ehehalt R, Hartmann P, Schreiber S. Bokemeyer B, et al. Among authors: mohl w. Inflamm Bowel Dis. 2024 May 2;30(5):746-756. doi: 10.1093/ibd/izad138. Inflamm Bowel Dis. 2024. PMID: 37523666
Profile of patients with inflammatory bowel disease in conjunction with unmet needs and decision-making for choosing a new biologic therapy: a baseline analysis of the VEDOIBD-Study.
di Giuseppe R, Plachta-Danielzik S, Mohl W, Hoffstadt M, Krause T, Bokemeyer B, Schreiber S. di Giuseppe R, et al. Among authors: mohl w. Int J Colorectal Dis. 2021 Nov;36(11):2445-2453. doi: 10.1007/s00384-021-03943-5. Epub 2021 May 8. Int J Colorectal Dis. 2021. PMID: 33963913
Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn's Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study.
Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Mohl W, Teich N, Hoffstadt M, Schweitzer A, von der Ohe M, Gauss A, Atreya R, Krause T, Blumenstein I, Hartmann P, Schreiber S. Bokemeyer B, et al. Among authors: mohl w. Inflamm Bowel Dis. 2023 Nov 2;29(11):1741-1750. doi: 10.1093/ibd/izac271. Inflamm Bowel Dis. 2023. PMID: 36633301
Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naïve patients with ulcerative colitis: A two-year propensity-score-adjusted analysis from the prospective, observational VEDOIBD -study.
Bokemeyer B, Plachta-Danielzik S, di Giuseppe R, Efken P, Mohl W, Krause T, Hoffstadt M, Ehehalt R, Trentmann L, Schweitzer A, Jessen P, Hartmann P, Schreiber S. Bokemeyer B, et al. Among authors: mohl w. Aliment Pharmacol Ther. 2023 Aug;58(4):429-442. doi: 10.1111/apt.17616. Epub 2023 Jun 15. Aliment Pharmacol Ther. 2023. PMID: 37322825
Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn's disease: results from a large case-control study.
Teich N, Mohl W, Primas C, Novacek G, Gauss A, Walldorf J, Felten G, Atreya R, Kruis W, Bettenworth D, Roznowski AB, Langhorst J, Schmidt K, Bruns T, Stallmach A; German IBD Study Group. Teich N, et al. Among authors: mohl w. Scand J Gastroenterol. 2020 Sep;55(9):1028-1034. doi: 10.1080/00365521.2020.1797869. Epub 2020 Jul 30. Scand J Gastroenterol. 2020. PMID: 32730708
Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases--A Prospective Study on Incidence and Severity.
Teich N, Mohl W, Bokemeyer B, Bündgens B, Büning J, Miehlke S, Hüppe D, Maaser C, Klugmann T, Kruis W, Siegmund B, Helwig U, Weismüller J, Drabik A, Stallmach A; German IBD Study Group. Teich N, et al. Among authors: mohl w. J Crohns Colitis. 2016 Jan;10(1):61-8. doi: 10.1093/ecco-jcc/jjv188. Epub 2015 Oct 13. J Crohns Colitis. 2016. PMID: 26468141 Free PMC article.
[Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease].
Teich N, Ludewig C, Schmelz R, Bästlein EC, Geißler S, Nagl S, Walldorf J, Krause T, Maaser C, Mohl W, Wedemeyer HH, Bauer T, Büning C, Grunert P, Hasselblatt P, Hänschen M, Kahl M, Engelke O, Schubert S, Holler B, Streetz K, Arnim UV, Schmidt K, Stallmach A; für die German IBD Study Group; Collaborators:; Jochen Maul, Berlin; Axel Schweitzer, Münster; Wolfgang Breit, Dinkelsbühl; Jan-Hinnerk Hofer, Köln; Marc Eisold, Mössingen; Michael R. Mroß, Berlin; Stefanie Howaldt, Hamburg; Stefanie Strobl, Ingolstadt; Robert Ehehalt, Heidelberg; Klaus Schmidt, Lübeck; Carsten Triller, Heinsberg; Serhat Aymaz, Düren; Thorsten Brechmann, Bochum; Axel Dignaß, Frankfurt; Elisabeth Schnoy, Augsburg; Bernd Swarovsky, Albstadt; Dr. med. Birgit Gerhard, Berlin; Doris Zink, Nürnberg; Ulrich Finger, Berlin; Franz Josef Heil, Andernach; Gerd-Rüdiger Franke, Dinkelsbühl; Günther Böhm, Ludwigshafen; Jens Hunkemöller, Oberberg; Martin Schmidt-Lauber, Oldenburg; Mirko Vonderach, Oldenburg; Olaf Mensler, Oberberg; Rainer Kunz, Fürstenfeldbruck; Richard Kölble, Düsseldorf; Christoph Rother, Sundern; Ulf Klönne, Göttingen; Ulrich Graefe, Berlin; Wolfgang Schwarz, Hamburg; Georg Schmitz, Düren; Hans Vi… See abstract for full author list ➔ Teich N, et al. Among authors: mohl w. Z Gastroenterol. 2021 Nov;59(11):1189-1196. doi: 10.1055/a-1508-6734. Epub 2021 Jul 16. Z Gastroenterol. 2021. PMID: 34748206 German.
116 results